Zdrowie i gospodarka · 12/06/2015
FDA Announces Draft Guidance on Assessing Male-Mediated Developmental Risk in Pharmaceuticals
The Food and Drug Administration (FDA) has released a draft guidance for industry on assessing risks to embryo/fetal development from pharmaceuticals administered to male participants in clinical trials, with the goal of mitigating these risks.